Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis

Creative Commons License

Erson-Omay E. Z., Caglayan A. O., Schultz N., Weinhold N., Omay S. B., ÖZDUMAN K., ...More

NEURO-ONCOLOGY, vol.17, no.10, pp.1356-1364, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 10
  • Publication Date: 2015
  • Doi Number: 10.1093/neuonc/nov027
  • Journal Name: NEURO-ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1356-1364
  • Bezmialem Vakıf University Affiliated: No


Background. Malignant high-grade gliomas (HGGs), including the most aggressive form, glioblastoma multiforme, show significant clinical and genomic heterogeneity. Despite recent advances, the overall survival of HGGs and their response to treatment remain poor. In order to gain further insight into disease pathophysiology by correlating genomic landscape with clinical behavior, thereby identifying distinct HGG molecular subgroups associated with improved prognosis, we performed a comprehensive genomic analysis.